Shuchun Wei

800 total citations
21 papers, 599 citations indexed

About

Shuchun Wei is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Shuchun Wei has authored 21 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Surgery and 6 papers in Cancer Research. Recurrent topics in Shuchun Wei's work include MicroRNA in disease regulation (6 papers), Inflammatory Bowel Disease (5 papers) and Circular RNAs in diseases (5 papers). Shuchun Wei is often cited by papers focused on MicroRNA in disease regulation (6 papers), Inflammatory Bowel Disease (5 papers) and Circular RNAs in diseases (5 papers). Shuchun Wei collaborates with scholars based in China. Shuchun Wei's co-authors include Lei Peng, Yini Dang, Huaiming Sang, Guoxin Zhang, Xuan Li, Duochen Jin, Xudong Zhu, Jixiang Zhang, Weiguo Dong and Yuanyuan Li and has published in prestigious journals such as Gastroenterology, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Shuchun Wei

20 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuchun Wei China 13 417 303 64 61 60 21 599
Chunjing Xu China 13 539 1.3× 416 1.4× 72 1.1× 66 1.1× 50 0.8× 19 727
Detao Yin China 15 528 1.3× 285 0.9× 64 1.0× 90 1.5× 71 1.2× 48 850
Yaser Mansoori Iran 18 594 1.4× 526 1.7× 33 0.5× 55 0.9× 44 0.7× 68 878
Chaoqun Ma China 16 501 1.2× 340 1.1× 28 0.4× 39 0.6× 101 1.7× 40 685
Haoyu Deng China 8 300 0.7× 230 0.8× 64 1.0× 48 0.8× 28 0.5× 16 461
Linhua Ji China 13 296 0.7× 150 0.5× 108 1.7× 40 0.7× 82 1.4× 35 500
Xinlian Chen China 11 304 0.7× 139 0.5× 48 0.8× 39 0.6× 74 1.2× 33 495
Risheng Cao China 13 297 0.7× 206 0.7× 43 0.7× 48 0.8× 107 1.8× 17 498
Xing Zhao China 14 671 1.6× 523 1.7× 31 0.5× 36 0.6× 25 0.4× 55 859

Countries citing papers authored by Shuchun Wei

Since Specialization
Citations

This map shows the geographic impact of Shuchun Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuchun Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuchun Wei more than expected).

Fields of papers citing papers by Shuchun Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuchun Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuchun Wei. The network helps show where Shuchun Wei may publish in the future.

Co-authorship network of co-authors of Shuchun Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Shuchun Wei. A scholar is included among the top collaborators of Shuchun Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuchun Wei. Shuchun Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Meilin, Shuchun Wei, Zixuan Xiang, et al.. (2024). 2ʹ-Hydroxycinnamaldehyde Alleviates Intestinal Inflammation by Attenuating Intestinal Mucosal Barrier Damage Via Directly Inhibiting STAT3. Inflammatory Bowel Diseases. 30(6). 992–1008. 7 indexed citations
2.
Su, Jing, Shuchun Wei, Wenjie Li, et al.. (2023). Clinicopathological characteristics of synchronous multiple primary early esophageal cancer and risk factors for multiple lesions. Frontiers in Oncology. 13. 1219451–1219451.
3.
Wei, Shuchun, Xiaohan Wu, Mengke Zhang, et al.. (2023). Dihydrokaempferol attenuates CCl4-induced hepatic fibrosis by inhibiting PARP-1 to affect multiple downstream pathways and cytokines. Toxicology and Applied Pharmacology. 464. 116438–116438. 13 indexed citations
4.
Liu, Chuan, Jixiang Zhang, Min Chen, et al.. (2023). Gender Differences in Psychological Symptoms and Quality of Life in Patients with Inflammatory Bowel Disease in China: A Multicenter Study. Journal of Clinical Medicine. 12(5). 1791–1791. 10 indexed citations
5.
Liao, Fei, et al.. (2023). Comprehensive analysis of endoplasmic reticulum stress-associated genes signature of ulcerative colitis. Frontiers in Immunology. 14. 1158648–1158648. 24 indexed citations
7.
Sang, Huaiming, Lei Peng, Shuchun Wei, et al.. (2022). Exosomal circRELL1 serves as a miR-637 sponge to modulate gastric cancer progression via regulating autophagy activation. Cell Death and Disease. 13(1). 56–56. 36 indexed citations
8.
Liu, Chuan, et al.. (2022). Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021. Frontiers in Immunology. 13. 972079–972079. 25 indexed citations
9.
Wei, Shuchun, Meilin Chen, Jinting Li, et al.. (2022). P2RY13 Exacerbates Intestinal Inflammation by Damaging the Intestinal Mucosal Barrier via Activating IL-6/STAT3 Pathway. International Journal of Biological Sciences. 18(13). 5056–5069. 51 indexed citations
10.
Liu, Chuan, Ting Wang, Jiahui Yang, et al.. (2022). Distant Metastasis Pattern and Prognostic Prediction Model of Colorectal Cancer Patients Based on Big Data Mining. Frontiers in Oncology. 12. 878805–878805. 20 indexed citations
11.
Wei, Shuchun, Jixiang Zhang, Meilin Chen, et al.. (2022). Fusobacterium nucleatum Extracellular Vesicles Promote Experimental Colitis by Modulating Autophagy via the miR-574-5p/CARD3 Axis. Inflammatory Bowel Diseases. 29(1). 9–26. 35 indexed citations
12.
Zhang, Jixiang, Xiaohan Wu, Shuchun Wei, et al.. (2022). Identified potential biomarkers may predict primary nonresponse to infliximab in patients with ulcerative colitis. Autoimmunity. 55(8). 538–548. 6 indexed citations
13.
Yang, Jiajia, Xuan Li, Shuchun Wei, et al.. (2021). Evaluation of the Diagnostic Potential of a Plasma Exosomal miRNAs Panel for Gastric Cancer. Frontiers in Oncology. 11. 683465–683465. 13 indexed citations
14.
Jin, Duochen, Lei Peng, Yini Dang, et al.. (2021). Circular RNA circDNA2 upregulates CCDC6 expression to promote the progression of gastric cancer via miR-149-5p suppression. Molecular Therapy — Nucleic Acids. 26. 360–373. 14 indexed citations
15.
Peng, Lei, Huaiming Sang, Shuchun Wei, et al.. (2020). circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2. Molecular Cancer. 19(1). 156–156. 191 indexed citations
16.
Peng, Lei, Yuanyuan Li, Shuchun Wei, et al.. (2020). LAMA4 activated by Androgen receptor induces the cisplatin resistance in gastric cancer. Biomedicine & Pharmacotherapy. 124. 109667–109667. 16 indexed citations
17.
Wei, Shuchun, Lei Peng, Jiajia Yang, et al.. (2020). Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer. Journal of Experimental & Clinical Cancer Research. 39(1). 32–32. 90 indexed citations
18.
Wei, Shuchun, et al.. (2020). Association between Helicobacter pylori infection and delayed growth in children: A meta‑analysis. Experimental and Therapeutic Medicine. 19(6). 3814–3828. 10 indexed citations
19.
Li, Xuan, et al.. (2019). A Prospective Randomized Trial to Assess the Antireflux Effect of Antireflux Mucosectomy in the Porcine Model. Gastroenterology Research and Practice. 2019. 1–6. 5 indexed citations
20.
Peng, Lei, Shuchun Wei, Xuan Li, et al.. (2019). Endoscopic removal of a migrated intrauterine contraceptive device in the rectum assisted by Overstitch defect closure. Endoscopy. 51(10). E276–E277. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026